Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CVKD | US
-0.21
-4.23%
Healthcare
Biotechnology
30/06/2024
10/04/2026
4.76
4.95
5.13
4.75
Cadrenal Therapeutics Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra Florida.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
160.5%1 month
114.8%3 months
106.2%6 months
110.6%-
-
5.11
0.00
0.00
0.21
-
-
-6.63M
5.63M
5.63M
-
-
-
-
-174.01
0.43
2.54
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.33
Range1M
3.98
Range3M
4.75
Rel. volume
0.87
Price X volume
184.52K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| QNCX | QNCX | Biotechnology | 0.1363 | 5.90M | 10.19% | n/a | 30.62% |
| Outlook Therapeutics Inc | OTLK | Biotechnology | 0.249 | 5.89M | 12.06% | n/a | -39.11% |
| Aptorum Group Limited | APM | Biotechnology | 0.91 | 4.98M | 9.43% | n/a | 13.53% |
| Immuron Limited | IMRN | Biotechnology | 0.793 | 4.82M | -0.88% | n/a | 1.37% |
| Xenetic Biosciences Inc | XBIO | Biotechnology | 3.06 | 4.72M | -2.86% | n/a | 0.00% |
| Neurotrope Inc | NTRP | Biotechnology | 2.96 | 4.69M | -6.18% | n/a | 0.00% |
| Brainstorm Cell Therapeutics Inc | BCLI | Biotechnology | 0.88 | 4.68M | n/a | -27.28% | |
| Alaunos Therapeutics Inc | TCRT | Biotechnology | 2.89 | 4.63M | 2.12% | n/a | 0.00% |
| Evogene Ltd | EVGN | Biotechnology | 0.8106 | 4.54M | -1.16% | n/a | 26.41% |
| NuCana plc | NCNA | Biotechnology | 1.97 | 4.43M | -6.19% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.34 | 3.42M | 3.08% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.2536 | 2.41M | -15.10% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.09 | 1.15M | 7.18% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.006 | 553.29K | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.21 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 5.11 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 106.22 | - | Riskier |
| Debt to Equity | 0.00 | -1.23 | Expensive |
| Debt to Assets | 0.00 | 0.25 | Cheaper |
| Market Cap | 5.63M | - | Emerging |